Mridula George
Associate Program Director, Breast Medical Oncology · Rutgers Health
Credentials: · · · · · ·
History
- Present
Breast Medical Oncology · Rutgers Health
- Present
- Present
- 2015–2018
Hematology and Medical Oncology
- 2008–2012
Research
Clinical and Pharmacologic Differences of CDK4/6 Inhibitors in Breast Cancer
Review · Frontiers in Oncology · 2021 · First of 5 authors · 129 citations
Psychoneurological symptom cluster in breast cancer: the role of inflammation and diet
Review · Breast Cancer Research and Treatment · 2020 · First of 3 authors · Corresponding · 52 citations
Immune Checkpoint Inhibitors in Triple Negative Breast Cancer: The Search for the Optimal Biomarker
Review · Biomarker Insights · 2022 · 26 citations
10 papers
9 papers
9 papers
7 papers
6 papers
6 papers
6 papers
6 papers · 4 as a resident
Clinical trials
- 2026–2029
SHORTened Duration of TAMoxifen
Principal investigator · Active not recruiting · Phase 2
Rutgers, The State University of New Jersey
- 2024–2032
RADIANT: Pre-op Radiation With Abemaciclib and Letrozole
Principal investigator · Recruiting · Phase 1
Mridula George, MD
- 2023–2027
OCTANE: Adjuvant Liposomal Doxorubicin and Carboplatin for Early-stage Triple-negative Breast Cancer
Principal investigator · Active not recruiting · Phase 2
Mridula George, MD
- 2022–2027
Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted
Principal investigator · Recruiting · Phase 2
Rutgers, The State University of New Jersey